CytoDyn Inc. (CYDY: OTCQB) | ASM Microbe 2019 Conf
Post# of 35809
(Total Views: 33)
Posted On: 04/04/2019 6:00:02 AM
CytoDyn Inc. (CYDY: OTCQB) | ASM Microbe 2019 Conference Grants Both Poster and Oral Presentations to CytoDyn for its Pivotal Study of Leronlimab (PRO 140) which Demonstrated Superior Efficacy and Safety in Heavily Treatment-Experienced HIV Patients
(0)
(0)